Strategy and market access firm Skysis joins Fishawack group
Fishawack has announced the addition of US consulting firm Skysis to its group.
The company focuses on connecting interdependencies across HCP, payer, channel, and patient stakeholders. It is the first acquisition with Fishawack Health’s new investor Bridgepoint.
Oliver Dennis, Fishawack Health co-founder and CEO, said: “In partnering with Bridepoint, we have made a step-change in our ambition. We’re delighted today to add Skysis to the group. They bring strategy and market access across the entire commercial life cycle, making them an important addition to our strategic consulting capabilities.”
Dawn Rich, managing director of Skysis, said: “Our team is thrilled to be joining the groups. Our core capabilities match perfectly with the key services of the wider consulting capability.”
Fishawack said it plans to “continue to add new capabilities designed to solve our client’s critical medical and commercial challenges in an integrated and seamless way”.
Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.